Items where authors include "White, H."

Article

Caley, L.R. orcid.org/0000-0001-8957-1018, Gillgrass, L., Zagoya, C. et al. (5 more authors) (2025) Longer term follow-up of abdominal symptoms (CFAbd-Score) after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis. Journal of Cystic Fibrosis, 24 (4). pp. 787-791. ISSN 1569-1993

Morgan, P.T., Ellis, T.-J., Smeuninx, B. et al. (6 more authors) (2025) Dietary protein intake and overall diet quality in adults with cystic fibrosis following elexacaftor/tezacaftor/ivacaftor therapy. British Journal Of Nutrition. ISSN 0007-1145

Varese, F. orcid.org/0000-0001-7244-598X, Allsopp, K. orcid.org/0000-0002-5093-0404, Carter, L.-A. et al. (21 more authors) (2025) Demographic, occupational factors and pandemic-related stressors associated with heightened mental health difficulties among UK health and social care workers supported by regional Resilience Hubs during the COVID-19 pandemic. BMJ Open, 15. e082817. ISSN 2044-6055

Allsopp, K., Varese, F., French, P. et al. (19 more authors) (2024) A service mapping exercise of four health and social care staff mental health and wellbeing services, resilience hubs, to describe health service provision and interventions. BMC Health Services Research, 24 (1). 430. ISSN 1472-6963

Caley, L.R. orcid.org/0000-0001-8957-1018, Wood, H.M. orcid.org/0000-0003-3009-5904, Bottomley, D. orcid.org/0009-0000-5749-2710 et al. (9 more authors) (2024) The gut microbiota in adults with cystic fibrosis compared to colorectal cancer. Journal of Cystic Fibrosis, 23 (2). pp. 262-268. ISSN 1569-1993

Ispoglou, T., McCullough, D., Windle, A. et al. (6 more authors) (2024) Addressing cancer anorexia-cachexia in older patients: Potential therapeutic strategies and molecular pathways. Clinical Nutrition, 43 (2). pp. 552-566. ISSN 0261-5614

Tavabie, O.D., Abbott, J., Abeysekera, K.W.M. et al. (97 more authors) (2024) Regional variations in inpatient decompensated cirrhosis mortality may be associated with access to specialist care: results from a multicentre retrospective study. Frontline Gastroenterology, 15 (1). pp. 3-13. ISSN 2041-4137

Caley, L.R. orcid.org/0000-0001-8957-1018, Jarosz-Griffiths, H.H. orcid.org/0000-0001-5154-4815, Smith, L. orcid.org/0000-0002-4280-6323 et al. (11 more authors) (2023) Body mass index and nutritional intake following Elexacaftor/Tezacaftor/Ivacaftor modulator therapy in adults with cystic fibrosis. Journal of Cystic Fibrosis, 22 (6). pp. 1002-1009. ISSN 1569-1993

Tavabie, O.D., Abbott, J., Abeysekera, K.W. et al. (97 more authors) (2023) Defining characteristics and outcomes for patients with non-alcoholic fatty liver disease admitted to hospital with decompensated cirrhosis. Journal of Hepatology, 79 (4). e165-e167. ISSN 0168-8278

Allsopp, K. orcid.org/0000-0002-5093-0404, Varese, F. orcid.org/0000-0001-7244-598X, French, P. et al. (14 more authors) (2023) Implementing psychological support for health and social care staff affected by the COVID-19 pandemic: a qualitative exploration of staff well-being hubs (‘Resilience Hubs’) using normalisation process theory. BMJ Open, 13 (8). e071826. ISSN 2044-6055

Tavabie, O.D., Abeysekera, K.W.M., Brennan, P.N. et al. (291 more authors) (2023) Regional variation in characteristics of patients with decompensated cirrhosis admitted to hospitals in the UK. The Lancet Gastroenterology & Hepatology, 8 (7). pp. 604-606. ISSN 2468-1253

Campbell, F. orcid.org/0000-0002-4141-8863, Tricco, A.C., Munn, Z. et al. (5 more authors) (2023) Mapping reviews, scoping reviews, and evidence and gap maps (EGMs): the same but different— the “Big Picture” review family. Systematic Reviews, 12. 45. ISSN 2046-4053

Poole, A.P., Finnis, M.E., Anstey, J. et al. (106 more authors) (2022) The effect of a liberal approach to glucose control in critically ill patients with type 2 diabetes: a multicenter, parallel-group, open-label randomized clinical trial. American Journal of Respiratory and Critical Care Medicine, 206 (7). pp. 874-882. ISSN 1073-449X

King, L., White, H., Clifton, I. et al. (3 more authors) (2021) Nutritional status and intake in patients with non-cystic fibrosis bronchiectasis (NCFB) - a cross sectional study. Clinical Nutrition, 40 (9). pp. 5162-5168. ISSN 0261-5614

Saunderson, C.E.D., Paton, M.F. orcid.org/0000-0001-8517-4621, Brown, L.A.E. orcid.org/0000-0002-1327-6482 et al. (15 more authors) (2021) Detrimental Immediate- and Medium-Term Clinical Effects of Right Ventricular Pacing in Patients With Myocardial Fibrosis. Circulation: Cardiovascular Imaging, 14 (5). ARTN e012256. ISSN 1941-9651

Saunderson, C.E.D., Paton, M.F., Brown, L.A.E. et al. (15 more authors) (2021) Detrimental immediate and medium-term clinical effects of right ventricular pacing in patients with myocardial fibrosis. Circulation: Cardiovascular Imaging, 14 (5). e012256. ISSN 1941-9651

Collaboration, L.B.N.E., Adams, R., Adams, D. et al. (483 more authors) (2013) The Long-Baseline Neutrino Experiment: Exploring Fundamental Symmetries of the Universe.

Proceedings Paper

Caley, L.R. orcid.org/0000-0001-8957-1018, Morgan, P.T., Ellis, T.-J. et al. (6 more authors) (2025) WS12.02Dietary protein intake and overall diet quality in adults with cystic fibrosis following elexacaftor/tezacaftor/ivacaftor therapy. In: Journal of Cystic Fibrosis. 48th European Cystic Fibrosis Conference, 04-07 Jun 2025, Milan, Italy. Elsevier .

Caley, L. orcid.org/0000-0001-8957-1018, Zagoya, C., White, H. et al. (3 more authors) (2025) Associations between changes in CFAbd-Score, dietary intake and weight following Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy: preliminary analysis. In: Journal of Cystic Fibrosis. 47th European Cystic Fibrosis Conference, 05 Jun 2024 - 08 Jun 2025, Glasgow, UK. Elsevier .

Gillgrass, L., Caley, L. orcid.org/0000-0001-8957-1018, Zagoya, C. et al. (5 more authors) (2024) P318 Abdominal symptoms after longer term use of elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis. In: Journal of Cystic Fibrosis. 47th European Cystic Fibrosis Conference, 05 Jun 2024 - 08 Jun 2025, Glasgow, UK. Elsevier .

Caley, L.R. orcid.org/0000-0001-8957-1018, de Goffau, M., Marsh, R. et al. (8 more authors) (2024) WS04.03 Associations between nutrient intake, SCFA levels and the faecal microbiota in adults with cystic fibrosis: preliminary analysis. In: Journal of Cystic Fibrosis. 47th European Cystic Fibrosis Conference, 05 Jun 2024 - 08 Jun 2025, Glasgow, UK. Elsevier .

Caley, L. orcid.org/0000-0001-8957-1018, de Goffau, M.C., Jones, A.M. et al. (6 more authors) (2023) EPS5.01 Change in gut microbiota following elexacaftor/tezacaftor/ivacaftor (ETI) therapy: preliminary analysis. In: Journal of Cystic Fibrosis. 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria. Elsevier .

Caley, L.R. orcid.org/0000-0001-8957-1018, Jarosz-Griffiths, H.H., Smith, L. et al. (11 more authors) (2023) EPS5.06 Changes in body mass index, energy, fat and sodium intake with triple CFTR modulator therapy preliminary analysis. In: Journal of Cystic Fibrosis. 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria. Elsevier .

Caley, L.R. orcid.org/0000-0001-8957-1018, Zagoya, C., White, H. et al. (3 more authors) (2022) P177 Adults with Cystic Fibrosis-Related Diabetes have a significantly elevated rate of gastrointestinal symptoms assessed with the CFAbd-Score. In: Journal of Cystic Fibrosis. 45th European Cystic Fibrosis Conference, 08-11 Jun 2022, Rotterdam, The Netherlands. Elsevier , S115-S115.